Adverse events · Adults treated for periodontitis and receiving supportive periodontal therapy (SPT)
1 finding from 1 review
Adverse events · participants with cancer treated with chemotherapy
1 finding from 1 review
Adverse events · participants with cancer treated with radiotherapy (with or without chemotherapy)
1 finding from 1 review
Adverse events · participants with cancer treated with radiotherapy (with or without chemotherapy)
2 findings from 1 review
Adverse events · adults and children with initial sepsis and septic shocka
Liberal initial fluid showed no clear difference in adverse events compared with conservative fluid therapy (low certainty).
1 finding from 1 review
Adverse events · Adults undergoing pelvic radiotherapy
1 finding from 1 review
no estimate extracted
905 participants
Very low
Adverse events · Participants with Crohn's disease in remission
Usual care showed no clear difference in adverse events compared with immunosuppressive withdrawal after monotherapy (low certainty).
1 finding from 1 review
Adverse events · Participants with Crohn's disease in remission
Usual care showed no clear difference in adverse events compared with immunosuppressive withdrawal after combination therapy (low certainty).
1 finding from 1 review
Adverse events · Adults treated for periodontitis and receiving supportive periodontal therapy (SPT)
The review found no eligible studies for this question.
1 finding from 1 review
Not measured
0 studies
No studies found
Adverse events · participants with advanced cancer who have nausea and vomiting not related to chemotherapy, radiotherapy, or surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Adverse events · cancer patients receiving myelotoxic chemotherapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · people with cardiac channelopathies
Implantable cardioverter defibrillators showed no clear difference in adverse events compared with β‐blocker therapy (low certainty).
1 finding from 1 review
Number of participants reporting an adverse event · patients with Helicobacter pylori infection
PPI triple therapy for 10 days showed no clear difference in patients with adverse events, regardless of regimen and dose compared with 7 days (moderate certainty).
1 finding from 1 review
Number of participants reporting an adverse event · patients with Helicobacter pylori infection
PPI triple therapy for 14 days showed no clear difference in patients with adverse events, regardless of regimen and dose compared with 10 days (low certainty).
1 finding from 1 review
Number of participants reporting an adverse event · patients with Helicobacter pylori infection
PPI triple therapy for 14 days probably leads to higher patients with adverse events, regardless of regimen and dose compared with 7 days (moderate certainty).
1 finding from 1 review
Adverse eventsCumulative incidence · men with lower urinary tract symptoms secondary to benign prostatic obstruction
Serenoa repens in combination with other phytotherapy showed no clear difference in adverse eventsCumulative incidence compared with placebo or no intervention (low certainty).
1 finding from 1 review
Adverse events (grade ≥ 3) · recurrent platinum‐resistant EOC
Summary of findings 3: PLD with chemotherapy probably leads to higher overall severe adverse events (grade ≥ 3) compared with PLD alone (moderate certainty).
1 finding from 1 review
Adverse events: any antibiotic‐related adverse event leading to discontinuation of therapy · women with PID
It is very uncertain whether regimens containing quinolone changes adverse events: any antibiotic‐related adverse event leading to… compared with regimens containing cephalosporins (very low certainty).
1 finding from 1 review
RR 2.24 [0.52, 9.72]
Studies not reported
Very low
Adverse events: any antibiotic‐related adverse event leading to discontinuation of therapy · women with PID
Regimens containing nitroimidazole showed no clear difference in adverse events: any antibiotic‐related adverse event leading to… compared with no nitroimidazole (low certainty).
1 finding from 1 review
RR 1.05 [0.69, 1.61]
Studies not reported
Low
Adverse events: any antibiotic‐related adverse event leading to discontinuation of therapy · women with PID
It is very uncertain whether regimens containing clindamycin plus aminoglycoside changes adverse events: any antibiotic‐related adverse event leading to… compared with regimens containing quinolone (very low certainty).
1 finding from 1 review
RR 0.21 [0.02, 1.72]
Studies not reported
Very low